...BRCA1 are also determinants of response to cisplatin/gemcitabine, with low levels of mRNA predicting improved survival. ...
...BRCA1 and BRCA2. How this complex interacts with damaged DNA is unknown, as only the FA core protein FANCM (the homolog ...
...BRCA1 and BRCA2 expression.,The data indicated that low protein expression of BRCA1 and BRCA2 was frequent in lung adeno...
...BRCA1 mutations. In addition, we were able to show that the site of the BRCA1 mutation does not influence the effect of ...
...BRCA1 since expression of exogenous BRCA1 restored the ability of these cells to induce FANCD2 foci following cisplatin ...
...BRCA1 and BRCA2 account for the majority of hereditary breast/ovarian cancer cases. The analysis of BRCA1 gene was carri...
...BRCA1/2 gene mutation.,Data was collected in a pilot study that assessed the response of women to an information booklet...
Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2...
...BRCA1 C-terminal (BRCT) domain of TopBP1 interacts with a protein fragment of PARP-1 in vitro containing the DNA-binding...
As sequence analysis for BRCA1 and BRCA2 mutations is both time- and cost-intensive, current strategies often include sc...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
